| Website | flagshipventures.com |
| @FlagshipVenture | |
| Phone | 617 868 1888 |
| Employees | |
| Founded | 2000 |
| Flagship Ventures Fund IV, 1/12 | $270M |
Realizing entrepreneurial innovation is the mission of Flagship Ventures. The firm operates through two synergistic units: VentureLabs(TM) which invents and launches transformative companies, and Venture Capital, which finances and realizes innovative, early-stage companies. Founded in 2000, and based in Cambridge, Massachusetts, Flagship Ventures manages over $900 million in capital. The Flagship team innovates and invests in three principal business sectors: therapeutics, health technologies and sustainability/clean technology. Past successful Flagship portfolio ventures include: Adnexus (acquired by Bristol-Myers Squibb), Accuri Cytometers (acquired by Becton, Dickinson), Morphotek (acquired by Eisai), Color Kinetics (acquired by Philips), AVEO (NASDAQ: AVEO) and BG Medicine (NASDAQ: BGMD). Recent notable portfolio ventures include: Joule Unlimited, Agios, Affinnova, AeroDesigns and Novomer. For more information, please visit www.flagshipventures.com.
| Company | Date | Round | Size | Participants |
| Syros Pharmaceuticals | 4/13 | Series A | $30M | 2 |
| TARIS Biomedical | 3/13 | Private Equity | $13.5M | 4 |
| Avedro | 3/13 | Series D | $43M | 8 |
| Blend Therapeutics | 12/12 | Series B | $16M | 3 |
| Moderna Therapeutics | 12/12 | Venture Round | $40M | 1 |
| Quanterix | 11/12 | Series C | $18.5M | 4 |
| Visterra | 11/12 | Series A | $13M | 5 |
| WikiCell Designs | 9/12 | Series A | $10M | 2 |
| Seventh Sense Biosystems | 6/12 | Series A | $10M | 2 |
| Eleven Biotherapeutics | 5/12 | Series A | $20M | 3 |
| Polatis | 2/12 | Venture Round | $2.7M | 5 |
| Blend Therapeutics | 1/12 | Series A | $2.8M | 2 |
| Agios Pharmaceuticals | 11/11 | Series C | $78M | 4 |
| T2 Biosystems | 8/11 | Series D | $23M | 10 |
| Kovio | 6/11 | Venture Round | $15M | 7 |
| ExactCost | 6/11 | Venture Round | $8.5M | 1 |
| Seventh Sense Biosystems | 5/11 | Series A | $4.5M | 3 |
| TARIS Biomedical | 4/11 | Series B | $18.3M | 4 |
| LS9 | 12/10 | Series D | $30M | 5 |
| Accuri Cytometers | 10/10 | Series E | $6M | 5 |
| Visterra | 8/10 | Series A | $6M | 3 |
| Bind Biosciences | 6/10 | Series C | $12.4M | 4 |
| Acceleron Pharma | 6/10 | Venture Round | $8.4M | 5 |
| Everyday Solutions | 6/10 | Venture Round | $2.81M | 3 |
| Tetraphase Pharmaceuticals | 6/10 | Series C | $45M | 6 |
| T2 Biosystems | 5/10 | Series C | $15M | 9 |
| Joule Unlimited | 4/10 | Series B | $30M | 1 |
| Selecta Biosciences | 4/10 | Series C | $15M | 5 |
| TransMedics | 3/10 | Series E | $36M | 11 |
| Eleven Biotherapeutics | 3/10 | Series A | $35M | 2 |
| Receptos | 11/09 | Series A | $25M | 4 |
| LS9 | 10/09 | Series C | $25M | 4 |
| Alvine Pharmaceuticals | 9/09 | Series A | $21.5M | 6 |
| Pervasis Therapeutics | 8/09 | Series C | $17.4M | 3 |
| Accuri Cytometers | 8/09 | Series D | $4M | 5 |
| Advanced Electron Beams | 8/09 | Series C | $14.2M | 6 |
| Novomer | 8/09 | Series B | $14M | 4 |
| Kovio | 7/09 | Series E | $20M | 11 |
| TARIS Biomedical | 6/09 | Series A | $15M | 3 |
| Polatis | 6/09 | Venture Round | $8M | 7 |
| Carbon Design Systems | 5/09 | Series E | $7.5M | 3 |
| Parasol Therapeutics | 5/09 | Series A | $3.25M | 3 |
| Seahorse Bioscience | 3/09 | Series D | $6M | 7 |
| Selecta Biosciences | 2/09 | Series B | $15.1M | 4 |
| Black Duck Software | 2/09 | Series D | $9.5M | 8 |
| Tetraphase Pharmaceuticals | 8/08 | Series A | $15M | 5 |
| Mascoma | 5/08 | Series C | $61M | 4 |
| Concert Pharmaceuticals | 4/08 | Series C | $37M | 12 |
| Pervasis Therapeutics | 1/08 | Venture Round | $9.75M | 4 |
| Carbon Design Systems | 1/08 | Venture Round | $6M | 3 |
| Novomer | 11/07 | Series A | $6.6M | 2 |
| BDNA | 10/07 | Series D | $20M | 4 |
| Interactive Supercomputing | 10/07 | Series B | $11M | 5 |
| LS9 | 10/07 | Series B | $15M | 3 |
| Kovio | 9/07 | Series D | $19.5M | 10 |
| Adnexus | 8/07 | Series C | $15.5M | 5 |
| Tira Wireless | 7/07 | Series D | $5M | 4 |
| TransMedics | 4/07 | Series D | $25.5M | 9 |
| Netuitive | 4/07 | Series D | $8M | 7 |
| LS9 | 3/07 | Series A | $5M | 2 |
| Black Duck Software | 2/07 | Series C | $12M | 6 |
| Codon Devices | 12/06 | Series B | $20M | 5 |
| Concert Pharmaceuticals | 11/06 | Series B | $48.5M | 8 |
| Mascoma | 11/06 | Venture Round | $30M | 7 |
| SiCortex | 10/06 | Series B | $21M | 6 |
| Carbon Design Systems | 9/06 | Series D | $5M | 3 |
| Acceleron Pharma | 8/06 | Series B | $30M | 6 |
| Adnexus | 6/06 | Series B | $27M | 4 |
| Zingku | 6/06 | Venture Round | $1M | 1 |
| Tira Wireless | 3/06 | Series C | $13M | 2 |
| Interactive Supercomputing | 1/06 | Series A | $4.5M | 3 |
| Calpurnia Corporation | 1/06 | Series B | $8M | 4 |
| T2 Biosystems | 1/06 | Venture Round | $5.5M | 3 |
| Carbon Design Systems | 9/05 | Series C | $5.35M | 3 |
| Pervasis Therapeutics | 8/05 | Series B | $17.4M | 3 |
| Extraprise | 8/05 | Venture Round | $5.1M | 8 |
| Ellacoya Networks | 7/05 | Venture Round | $13.5M | 5 |
| Black Duck Software | 6/05 | Series B | $12M | 6 |
| Codon Devices | 5/05 | Series A | $13M | 3 |
| Netuitive | 5/05 | Series C | $5M | 5 |
| Tira Wireless | 3/05 | Series B | $2.5M | 3 |
| Revivio | 1/05 | Series C | $25M | 7 |
| Integrated Development Enterprise | 1/05 | Venture Round | $1.5M | 4 |
| Affinnova | 8/04 | Series C | $4.5M | 2 |
| Black Duck Software | 7/04 | Series A | $5M | 3 |
| ZoomInfo | 7/04 | Series A | $7M | 5 |
| Ensemble Discovery | 5/04 | Series A | $15M | 3 |
| TransMedics | 1/04 | Series B | $27.6M | 8 |
| Affinnova | 7/03 | Series B | $6M | 1 |
| TripAdvisor | 1/00 | Series A | 2 |
